Healthcare -
Biotechnology - NASDAQ - US
$ 9.235
-2.69 %
$ 2.84 B
Market Cap
-51.31
P/E
FOLD - TOTAL RECEIVABLES
Total Receivables FOLD - Amicus Therapeutics, Inc.
101 M
LAST VALUE
23.58%
2 YEAR CAGR
24.88%
5 YEAR CAGR
0.00%
10 YEAR CAGR